Abeona Therapeutics Depreciation & Amortization 2011-2026 | ABEO

Annual Depreciation & Amortization Abeona Therapeutics

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
2.55 M	2 M	2.29 M	3.09 M	3.25 M	4.59 M	7.82 M	2.36 M	741 K	825 K	551 K	11 K	3 K	419 K	233 K

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
7.82 M	3 K	2.05 M

Quarterly Depreciation & Amortization Abeona Therapeutics

2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
600 K	600 K	534 K	-	500 K	500 K	491 K	-	500 K	600 K	661 K	-	800 K	800 K	811 K	-	2.44 M	1.64 M	817 K	-	847 K	834 K	2.06 M	-	2.03 M	2.06 M	1.66 M	-	505 K	290 K	174 K	-	138 K	207 K	250 K	-	222 K	181 K	174 K	-	151 K	132 K	118 K	-	1 K	1 K	-	-	-	1 K	1 K	29 K	18 K	19 K	54 K	-	56 K	59 K	61 K

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
2.44 M	1 K	560 K

Depreciation & Amortization of other stocks in the Biotechnology industry

Issuer	Depreciation & Amortization	Price	% 24h	Market Cap	Country
Amphastar Pharmaceuticals AMPH	31.6 M	$ 21.87	2.15 %	$ 1.02 B	USA
I-Mab IMAB	23.9 M	-	-	$ 866 M	China
Aeglea BioTherapeutics AGLE	744 K	-	-	$ 1.01 B	USA
Aptorum Group Limited APM	1.13 M	$ 0.94	5.23 %	$ 6.91 M	China
ACADIA Pharmaceuticals ACAD	920 K	$ 22.67	3.23 %	$ 3.76 B	USA
Esperion Therapeutics ESPR	105 K	$ 2.02	5.5 %	$ 420 M	USA
Advaxis ADXS	369 K	-	-9.65 %	$ 45.9 M	USA
AIkido Pharma AIKI	105 K	-	1.93 %	$ 17.4 M	USA
Galectin Therapeutics GALT	1 K	$ 2.45	5.15 %	$ 157 M	USA
Akouos AKUS	2.49 M	-	0.23 %	$ 488 M	USA
Allakos ALLK	6.14 M	-	-	$ 28.6 M	USA
Heron Therapeutics HRTX	2.31 M	$ 1.2	0.42 %	$ 200 M	USA
AlloVir ALVR	13 K	-	4.14 %	$ 49.1 M	USA
Ampio Pharmaceuticals AMPE	122 K	-	-11.43 %	$ 502 K	USA
Applied Molecular Transport AMTI	3.13 M	-	-	$ 10.1 M	USA
ImmuCell Corporation ICCC	2.78 M	$ 8.24	-1.38 %	$ 74.4 M	USA
Aeterna Zentaris AEZS	58 K	-	5.93 %	$ 314 M	Canada
Brainstorm Cell Therapeutics BCLI	199 K	-	-2.5 %	$ 5.88 M	USA
Aptinyx APTX	122 K	-	-39.0 %	$ 4.57 M	USA
AgeX Therapeutics AGE	100 K	-	-10.17 %	$ 12.2 K	USA
Aravive ARAV	886 K	-	-13.39 %	$ 1.45 M	USA
Aridis Pharmaceuticals ARDS	487 K	-	17.91 %	$ 11.1 M	USA
Applied Genetic Technologies Corporation AGTC	1.51 M	-	-	$ 26.5 M	USA
Aquestive Therapeutics AQST	548 K	$ 4.17	2.21 %	$ 446 M	USA
Arcutis Biotherapeutics ARQT	700 K	$ 23.73	2.02 %	$ 3.02 B	USA
Jaguar Health JAGX	1.91 M	$ 0.35	-9.42 %	$ 816 K	USA
Ayala Pharmaceuticals AYLA	162 K	-	-	$ 7.46 M	Israel
Autolus Therapeutics plc AUTL	8.3 M	$ 1.45	0.35 %	$ 386 M	Britain
Aptose Biosciences APTO	22 K	-	-45.71 %	$ 1.2 M	Canada
KalVista Pharmaceuticals KALV	969 K	$ 20.06	2.18 %	$ 1.08 B	Britain
AVROBIO AVRO	617 K	-	1083.1 %	$ 745 M	USA
Can-Fite BioPharma Ltd. CANF	24 K	$ 3.03	4.12 %	$ 4.99 M	Israel
BioDelivery Sciences International BDSI	140 K	-	-4.8 %	$ 255 M	USA
BeiGene, Ltd. BGNE	142 M	-	0.49 %	$ 251 B	Cayman-islands
Akero Therapeutics AKRO	18 K	-	-	$ 3.67 B	USA
Ligand Pharmaceuticals Incorporated LGND	35.2 M	$ 233.96	1.16 %	$ 4.28 B	USA